Microsoft Corporation (MSFT), Intel Corporation (INTC) Among This Mega-Hedge Fund’s Top Picks

RENAISSANCE TECHNOLOGIESEarlier this month billionaire Jim Simons and his firm Renaissance Technologies filed its third quarter 13F, where notable investors and hedge funds are required to disclose their quarterly public equity holdings to the SEC. Jim Simons founded Renaissance Technologies in 1982 and now has over $15 billion of AUM. Simons retired in early 2010, but still has some capital invested in the fund. By analyzing Renaissance’s recent 13F we have identified the fund’s top holdings as of the end of 3Q. Check out all of RenTech’s top picks.

Microsoft Corporation (NASDAQ:MSFT) was Renaissance’s top pick in 3Q with over 1.4% of the fund’s 13F invested in the tech giant. Revenues are expected to rise 9% in 2013 and then 7% in 2014 on the back of Windows Live revenues being up 18% in 2013. The diverse tech company has recently launched new products that include Windows 8 and the Surface tablet, which should drive interim growth. This tech company appears to be offering a very good dividend (3.4% yield) and growth on a cheap basis – Microsoft’s trailing P/E comes in at 15x, but its forward ratio of only 8x suggest investors. Microsoft is also a top tech stock owned by hedge funds in 3Q (see our full top 10 here).

Eli Lilly & Co. (NYSE:LLY) saw Renaissance  dumping 18% of its shares during 3Q, but Eli remained the fund’s second largest 13F holding. Trading at 13x earnings, Eli is on the very low end of this range, compared to Pfizer and Merck, both trading at 20x earnings. On the surface, Eli looks like a cheap investment, but its five-year expected EPS, which is expected to decline 4% annually, causes some concern. Eli plans to grow sales by entering emerging markets and Japan, but we remain cautious and believe better value can be found in other pharma companies such as Bristol Myers. Eli Lilly is one of billionaire Stanley Druckenmiller’s top dividend picks (see all of his picks here).

Intel Corporation (NASDAQ:INTC) was a 10% share increase from 2Q for Renaissance. The chip maker continues to pay one of the largest dividends in the space with a 4.6% yield. Softness in PC sales has pressured the company of late, with sales expected to be down 1% by year’s end. The stock’s recent pull back has put Intel in an attractive valuation range, trading at a mere 8.5x earnings and a PEG ratio of 0.8. Intel expects to counter a slowing of PC sales with data center growth; we don’t see a value trap here, only a value play.

Bristol Myers Squibb Co. (NYSE:BMY) was Renaissance’s fourth spot in its 13F for 3Q. Another one of Renaissance’s pharma picks, we believe that Bristol has better prospects when compared to Eli. Bristol pays a dividend yielding over 4%, but does trade at 30x – the upper end of the pharma industry. On a forward earnings basis, Bristol is much more in line with its peers at 18x. Driving Bristol’s future growth and market share gains will be the recent acquisition of Amylin Pharmaceuticals. We see the pharma’s dividend and over discounted future earnings as a reason for investors to take a closer look at the stock.

Phillip Morris International Inc. (NYSE:PM) comprises nearly $320 million worth of RenTech’s capital, and pays a rather strong dividend at 3.8%. This non-US, international only, tobacco company trades in line with its major competitors at 19x trailing earnings, but its forward P/E of 15x makes it an attractive buy. Growing health concerns and higher taxes on the company’s products are headwinds for Philip Morris, but a three year cost reduction program should help mitigate revenue loss with margin expansion. Phillip also has the opportunity to grow in markets that it has little exposure to, including China and India.

We believe Microsoft may finally be breaking out of its trading shell and is poised for share appreciation given its robust product offering. The tech giant also pays a healthy dividend for those who decide to wait and see how its new OS and tablet impact earnings. We prefer the dividend that Bristol and Intel pay relative to the other dividend-payer Eli, but also like Phillip Morris’ potential.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!